The determinants of pharmaceutical research and development expenditures
β Scribed by Henry Grabowski; John Vernon
- Publisher
- Springer-Verlag
- Year
- 2000
- Tongue
- English
- Weight
- 137 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0936-9937
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The process by which pharmaceuticals are bought and sold is exceedingly complex. The major reason is that most consumers do not pay directly for the drugs they consume. Intermediaries are generally present who purchase pharmaceuticals from their manufacturers and have them provided to t
The emergence of the Israeli biotech industry parallels other high technology initiatives in Israel. While comparatively young compared with the US and emerging European biotech industries, the Israeli biotech industry has been very productive in collaboration with scientists from the centers of hig
## Abstract Notβforβprofit or nonprofit organizations (NPOs) are playing an increasingly important role in providing solutions to the significant challenges faced by both large pharmaceutical and smaller biotechnology companies in today's world. NPOs chartered for the public benefit are common in t